The pharmaceutical/animal health research community strives to exceed what is legally required for compliance.
Research animals are purpose-bred, meaning they are born and raised in carefully controlled conditions and environments that support animal well-being. The health and welfare of these animals is essential for ethics, drug safety, and reliable and reproducible science.
We abide by the 3Rs principles of animal research, and researchers must give strong justification to demonstrate their commitment to Reduction of animals used, Refinement of procedures to enhance animal welfare, and Replacement of animals with other methods (when available). The 3Rs principles are a framework to ensure high animal welfare and high-quality science and ultimately improve the lives of people and animals. Many institutions have programs that specifically promote the 3Rs through awards or other forms of recognition. Some have dedicated 3Rs scientists, animal welfare or behavior experts, and/or 3Rs committees to identify and create new ways to advance the 3Rs. Read more about IOC institutional commitments to animal welfare below:
- Abbvie’s comment to responsible use of animals in research
- Amgen’s commitment to ethical use of animals in research
- Bristol-Myers Squibb’s commitment to the ethical use and humane care of animals in research
- Charles River Laboratory’s commitment to humane care & well-being of research animal models
- Eli Lily’s commitment to responsible animal research
- Glaxo Smith Kline’s commitment to animal welfare
- Janssen’s commitment to decrease animal testing
- Marshall BioResources’ dedication to maintaining high standards of animal welfare
- Novartis’s commitments to animal welfare
- Sanofi’s commitment to responsible use of animals in research and production
- Taconic’s commitment to animal welfare